Autoantibody-Mediated IL-6–Dependent Endothelin-1 Elevation Underlies Pathogenesis in a Mouse Model of Preeclampsia

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of Immunology

• Publication date

  2011-05-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.4049/jimmunol.1004026PMID 21482739PMCID PMC3269191
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Elevated Maternal Soluble Gp130 and IL-6 Levels and Reduced Gp130 and SOCS-3 Expressions in Women Complicated With Preeclampsia

  2011cited by this paper
• Angiotensin Receptor Agonistic Autoantibody Is Highly Prevalent in Preeclampsia: Correlation With Disease Severity

  2010cited by this paper
• Angiotensin Receptor Agonistic Autoantibody–Mediated Tumor Necrosis Factor-&agr; Induction Contributes to Increased Soluble Endoglin Production in Preeclampsia

  2010cited by this paper
• Autoantibody-Mediated Angiotensin Receptor Activation Contributes to Preeclampsia Through Tumor Necrosis Factor-&agr; Signaling

  2010cited by this paper
• Endothelin, hypertension and chronic kidney disease: new insights

  2010cited by this paper
• Evaluation of anti-IL-6 monoclonal antibody therapy using murine type II collagen-induced arthritis

  2009cited by this paper
• IL-6 stimulates system A amino acid transporter activity in trophoblast cells through STAT3 and increased expression of SNAT2.

  2009cited by this paper
• Hypertension in Response to Autoantibodies to the Angiotensin II Type I Receptor (AT1-AA) in Pregnant Rats: Role of Endothelin-1

  2009cited by this paper
• Endothelin receptor antagonists as antihypertensives: the next frontier

  2009cited by this paper
• The detrimental role of angiotensin receptor agonistic autoantibodies in intrauterine growth restriction seen in preeclampsia

  2009cited by this paper
• Endothelin receptor antagonism prevents hypoxia-induced mortality and morbidity in a mouse model of sickle-cell disease.

  2008cited by this paper
• The endothelin-converting enzyme-1/endothelin-1 pathway plays a critical role in inflammation-associated premature delivery in a mouse model.

  2008cited by this paper
• Pathophysiology of hypertension during preeclampsia: linking placental ischemia with endothelial dysfunction.

  2008cited by this paper
• Autoantibody From Women With Preeclampsia Induces Soluble Fms-Like Tyrosine Kinase-1 Production via Angiotensin Type 1 Receptor and Calcineurin/Nuclear Factor of Activated T-Cells Signaling

  2008cited by this paper
• Antiphospholipid antibodies and pregnancy loss: a disorder of inflammation.

  2008cited by this paper
• Angiotensin receptor agonistic autoantibodies induce pre-eclampsia in pregnant mice

  2008cited by this paper
• Plasma nitric oxide, endothelin‐1, arginase and superoxide dismutase in pre‐eclamptic women

  2008cited by this paper
• Soluble endoglin and other circulating antiangiogenic factors in preeclampsia

  2007cited by this paper
• [Endothelin 1 and angiotensin II in preeeclampsia].

  2007cited by this paper
• Angiotensin II Induces Soluble fms-Like Tyrosine Kinase-1 Release via Calcineurin Signaling Pathway in Pregnancy

  2007cited by this paper
• Classic interleukin-6 receptor signaling and interleukin-6 trans-signaling differentially control angiotensin II-dependent hypertension, cardiac signal transducer and activator of transcription-3 activation, and vascular hypertrophy in vivo.

  2007cited by this paper
• The role of the immune system in preeclampsia.

  2007cited by this paper
• Angiotensin II hypertension is attenuated in interleukin-6 knockout mice.

  2006cited by this paper
• Inflammation and pre-eclampsia.

  2006cited by this paper
• Soluble endoglin and other circulating antiangiogenic factors in preeclampsia.

  2006cited by this paper
• Enhanced Endothelin Synthesis by Endothelial Cells Exposed to Sera From Pregnant Rats With Decreased Uterine Perfusion

  2006cited by this paper
• Profile of Past and Current Clinical Trials Involving Endothelin Receptor Antagonists: The Novel “-Sentan” Class of Drug

  2006cited by this paper
• Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction

  2006cited by this paper
• Characterizing the role of endothelin-1 in the progression of cardiac hypertrophy in aryl hydrocarbon receptor (AhR) null mice.

  2006cited by this paper
• Hypertension Produced by Reductions in Uterine Perfusion in the Pregnant Rat: Role of Interleukin 6

  2006cited by this paper
• Role of the renin-angiotensin system in the pathogenesis of preeclampsia.

  2005cited by this paper
• Role of Endothelin in Mediating Tumor Necrosis Factor-Induced Hypertension in Pregnant Rats

  2005cited by this paper
• Effects of Angiotensin II Receptor Blockade with Valsartan on Pro-Inflammatory Cytokines in Patients with Essential Hypertension

  2005cited by this paper
• Maternal autoantibodies from preeclamptic patients activate angiotensin receptors on human mesangial cells and induce interleukin-6 and plasminogen activator inhibitor-1 secretion.

  2005cited by this paper
• Latest Advances in Understanding Preeclampsia

  2005cited by this paper
• Endothelin inhibition delays onset of hyperglycemia and associated vascular injury in type I diabetes: evidence for endothelin release by pancreatic islet beta-cells.

  2005cited by this paper
• Lowering of blood pressure leads to decreased circulating interleukin-6 in hypertensive subjects

  2005cited by this paper
• Hypoxia Promotes Interleukin-6 and -8 but Reduces Interleukin-10 Production by Placental Trophoblast Cells From Preeclamptic Pregnancies

  2005cited by this paper
• Endothelin antagonism in pulmonary hypertension, heart failure, and beyond

  2005cited by this paper
• Antibiotic use in relation to the risk of breast cancer

  2004cited by this paper
• Plasma malondialdehyde, superoxide dismutase, sE-selectin, fibronectin, endothelin-1 and nitric oxide levels in women with preeclampsia.

  2004cited by this paper
• Transgenic mice for studies of the renin-angiotensin system in hypertension.

  2004cited by this paper
• Circulating angiogenic factors and the risk of preeclampsia.

  2004cited by this paper
• Interleukin-6 impairs endothelium-dependent NO-cGMP-mediated relaxation and enhances contraction in systemic vessels of pregnant rats.

  2004cited by this paper
• Antiinflammatory Effects of Angiotensin II Subtype 1 Receptor Blockade in Hypertensive Patients With Microinflammation

  2004cited by this paper
• Endothelin.

  2003cited by this paper
• AT1 Receptor Agonistic Antibodies From Preeclamptic Patients Stimulate NADPH Oxidase

  2003cited by this paper
• Hypoxia favours necrotic versus apoptotic shedding of placental syncytiotrophoblast into the maternal circulation.

  2003cited by this paper
• Trophoblast deportation and the maternal inflammatory response in pre-eclampsia.

  2003cited by this paper
• Pathophysiology of Preeclampsia: Linking Placental Ischemia/Hypoxia with Microvascular Dysfunction

  2002cited by this paper
• Antiandrogens in the treatment of priapism.

  2002cited by this paper
• Pathophysiology of hypertension during preeclampsia linking placental ischemia with endothelial dysfunction.

  2001cited by this paper
• Fetal programming and adult health

  2001cited by this paper
• Endothelin Type A Receptor Blockade Attenuates the Hypertension in Response to Chronic Reductions in Uterine Perfusion Pressure

  2001cited by this paper
• Pathogenesis and genetics of pre-eclampsia.

  2001cited by this paper
• Fetal nutrition and adult disease.

  2000cited by this paper
• Increased expression of interleukin 6 in term compared to the first trimester human placental villi.

  2000cited by this paper
• AT(1) receptor agonistic antibodies from preeclamptic patients cause vascular cells to express tissue factor.

  2000cited by this paper
• Role of endothelin-1 in hypertension

  1999cited by this paper
• Etiology and pathogenesis of preeclampsia: current concepts.

  1999cited by this paper
• Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor.

  1999cited by this paper
• Agonist-like activity of antibodies to angiotensin II receptor subtype 1 (AT1) from rats immunized with AT1 receptor peptide.

  1999cited by this paper
• Evaluation of Nonspecific Immunity and Plasma Levels of Interferon-γ, Interleukin-6 and Tumor Necrosis Factor-α in Preeclampsia

  1999cited by this paper
• State-of-the-Art lecture. Role of endothelin-1 in hypertension.

  1999cited by this paper
• Evaluation of nonspecific immunity and plasma levels of interferon-gamma, interleukin-6 and tumor necrosis factor-alpha in preeclampsia.

  1999cited by this paper
• State-of-the-Art lecture: influence of exercise training on neurogenic control of blood pressure in spontaneously hypertensive rats.

  1999cited by this paper
• Circulating Levels of Immunoreactive Cytokines in Women with Preeclampsia

  1998cited by this paper
• Elevated IL‐6 in Midtrimester Amniotic Fluid Is Involved with the Onset of Preeclampsia

  1998cited by this paper
• Plasma Active Renin, Angiotensin I, and Angiotensin II During Pregnancy and in Preeclampsia

  1998cited by this paper
• Etiology and pathogenesis of preeclampsia: current concepts.

  1998cited by this paper
• Role for endothelin-1 in angiotensin II-mediated hypertension.

  1997cited by this paper
• Endothelin-1 transgenic mice develop glomerulosclerosis, interstitial fibrosis, and renal cysts but not hypertension.

  1997cited by this paper
• An orally active ETA/ETB receptor antagonist ameliorates proteinuria and glomerular lesions in rats with proliferative nephritis.

  1996cited by this paper
• Interleukin-6, tumour necrosis factor and soluble tumour necrosis factor receptors in women with pre-eclampsia.

  1995cited by this paper
• Interleukin‐6, turnour necrosis factor and soluble turnour necrosis factor receptors in women with pre‐eclampsia

  1995cited by this paper
• Effect of a Specific Endothelin Receptor A Antagonist on mRNA Levels for Extracellular Matrix Components and Growth Factors in Diabetic Glomeruli

  1995cited by this paper
• Endothelial cell activation by tumour necrosis factor‐alpha (TNF‐α and the development of pre‐eclampsia

  1994cited by this paper
• Bioactive tumour necrosis factor alpha in pre-eclamptic patients with and without the HELLP syndrome.

  1994cited by this paper
• Bioactive tumour necrosis factor α in pre‐eclamptic patients with and without the HELLP syndrome

  1994cited by this paper
• Interleukin-6 levels in amniotic fluid in normal and abnormal pregnancies: preeclampsia, small-for-gestational-age fetus, and premature labor.

  1993cited by this paper
• Endothelial vasoactive mediators in preeclampsia.

  1993cited by this paper
• Choriodecidual production of interleukin‐8 and mechanism of parturition

  1992cited by this paper
• The renin-angiotensin-aldosterone system in preeclampsia. A review.

  1991cited by this paper
• Increased plasma levels of the novel vasoconstrictor peptide endothelin in severe pre-eclampsia.

  1991cited by this paper
• Potential role of endothelin-1 in normal and hypertensive pregnancies.

  1991cited by this paper
• Maternal plasma level of endothelin is increased in preeclampsia.

  1991cited by this paper
• Women with preeclampsia have higher plasma endothelin levels than women with normal pregnancies.

  1990cited by this paper

• Exploring the role of exosomal MicroRNAs as potential biomarkers in preeclampsia

  2024cites this paper
• Preeclampsia and the Kidney: Pathophysiology and Clinical Implications.

  2023cites this paper
• Preliminary evidence that blocking the uptake of placenta-derived preeclamptic extracellular vesicles protects the vascular endothelium and prevents vasoconstriction

  2023cites this paper
• HMGB1: a double-edged sword and therapeutic target in the female reproductive system

  2023cites this paper
• Endothelin-1 in Health and Disease

  2023cites this paper
• Hydroxychloroquine reduces hypertension and soluble fms-like kinase-1 in a Nω-nitro-l-arginine methyl ester-induced preeclampsia rat model

  2022cites this paper
• Posterior reversible encephalopathy syndrome and autoimmunity.

  2022cites this paper
• Echinochrome A Reverses Kidney Abnormality and Reduces Blood Pressure in a Rat Model of Preeclampsia

  2022cites this paper
• Structures and functions of cilia during vertebrate embryo development

  2022cites this paper
• Oxidative and Inflammatory Imbalance in Placenta and Kidney of sFlt1-Induced Early-Onset Preeclampsia Rat Model

  2022cites this paper
• Trophoblast-Derived Extracellular Vesicles Promote Preeclampsia by Regulating Macrophage Polarization

  2022cites this paper
• Levels of angiotensin II type-1 receptor antibodies and endothelin-1 type-A receptor antibodies correlate with antibody-mediated rejection and poor graft function in kidney-transplantation patients.

  2022cites this paper
• How Preeclampsia Occurs and Potential Therapies for Curing Preeclampsia

  2022cites this paper
• Salt, Aldosterone, and the Renin–Angiotensin System in Pregnancy

  2022cites this paper
• Tocilizumab-associated posterior reversible encephalopathy syndrome in giant-cell arteritis – case report

  2021cites this paper
• Recombinant Thrombomodulin Attenuates Preeclamptic Symptoms by Inhibiting High Mobility Group Box 1 in Mice.

  2021cites this paper
• Evaluation of right coronary vascular dysfunction in severe pulmonary hypertensive rats using synchrotron radiation microangiography.

  2021cites this paper
• New views on endothelial dysfunction in gestational hypertension and potential therapy targets.

  2021cites this paper
• The association of posterior reversible encephalopathy syndrome with COVID-19: A systematic review

  2021cites this paper
• Epigenetic processes during preeclampsia and effects on fetal development and chronic health.

  2021cites this paper
• Primary Cilia in Trophoblastic Cells

  2020cites this paper
• Animal Models of Preeclampsia

  2020cites this paper
• Study the Role of Interleukin-4, Interleukin-17 and Interleukin-35 in Diagnosis and Prognosis of Preeclampsia in Egyptian Patients

  2020cites this paper
• Current understanding of autoantibody against angiotensin II type 1 receptor in preeclampsia

  2020cites this paper
• Endothelin Type A Receptor Antibodies Are Associated With Angiotensin II Type 1 Receptor Antibodies, Vascular Inflammation, and Decline in Renal Function in Pediatric Kidney Transplantation

  2020cites this paper
• The Role of Angiotensin II Type 1 Receptor-Activating Antibodies in Vascular Inflammation

  2020influential citation
• Innate and Adaptive Immune Response in Preeclampsia

  2019cites this paper
• Sex differences in risk factors for vascular contributions to cognitive impairment & dementia.

  2019cites this paper
• Role of hypoxia‐inducible factor 1α as a potential biomarker for renal diseases—A systematic review

  2019cites this paper
• Lethal immunoglobulins: Autoantibodies and sudden cardiac death.

  2019cites this paper
• MicroRNAs in Preeclampsia.

  2018cites this paper
• The Endothelin System: A Critical Player in the Pathophysiology of Preeclampsia

  2018cites this paper
• Preeclampsia: From Inflammation to Immunoregulation

  2018cites this paper
• Hypertension: Focus on autoimmunity and oxidative stress.

  2018cites this paper
• The role of interleukins in preeclampsia: A comprehensive review

  2018cites this paper
• Effect of Irisin on Experimentally-Induced Preeclampsia in Female Albino Rats

  2018cites this paper
• Understanding mechanisms of hypertension in systemic lupus erythematosus

  2017cites this paper
• Recent Advances in Immunity and Hypertension

  2017cites this paper
• The Pregnant Adolescent : General Considerations

  2017cites this paper
• Alpha-1-antitrypsin suppresses oxidative stress in preeclampsia by inhibiting the p38MAPK signaling pathway: An in vivo and in vitro study

  2017cites this paper
• Role of disturbed fatty acids metabolism in the pathophysiology of diabetic erectile dysfunction

  2017cites this paper
• siRNA‑mediated knockdown of T‑bet and RORγt contributes to decreased inflammation in pre‑eclampsia.

  2017cites this paper
• Trigonelline Inhibits Inflammation and Protects β Cells to Prevent Fetal Growth Restriction during Pregnancy in a Mouse Model of Diabetes

  2017cites this paper
• Effect of a black cumin (Nigella sativa) ethanol extract on placental angiotensin II type 1-receptor autoantibody (AT1-AA) serum levels and endothelin-1 (ET-1) expression in a preeclampsia mouse model

  2017cites this paper
• Endothelin, sex, and pregnancy: unique considerations for blood pressure control in females.

  2016cites this paper
• PREECLAMPSIA: THE ROLES OF ACUTE INFLAMMATION AND INTRAUTERINE STRESS

  2016cites this paper
• The role of inflammation in the pathology of preeclampsia.

  2016cites this paper
• Identifying immune mechanisms mediating the hypertension during preeclampsia.

  2016cites this paper
• IL-6 Trans-Signaling Drives Murine Crescentic GN.

  2016cites this paper
• The emerging role of endothelin-1 in the pathogenesis of pre-eclampsia

  2016cites this paper
• Vitamin D supplementation improves pathophysiology in a rat model of preeclampsia.

  2016cites this paper
• Identification of a Novel Agonist-Like Autoantibody in Preeclamptic Patients.

  2015cites this paper
• Differential regulation of TNF receptors in maternal leukocytes is associated with severe preterm preeclampsia

  2015cites this paper
• Hypoxia-Mediated Soluble Fms-Like Tyrosine Kinase 1 Increase Is Not Attenuated in Interleukin 6-Deficient Mice

  2015cites this paper
• Vitamin D supplementation improves pathophysiology in a rat

  2015cites this paper
• The role of microRNAs on angiogenesis and vascular pressure in preeclampsia: The evidence from systematic review

  2015cites this paper
• The Renin-Angiotensin System, its Autoantibodies, and Body Fluid Volume in Preeclampsia

  2015cites this paper
• Regulator of G protein signaling 5 is a determinant of gestational hypertension and preeclampsia

  2015cites this paper
• NLRP3 Deficiency Improves Angiotensin II-Induced Hypertension But Not Fetal Growth Restriction During Pregnancy.

  2015cites this paper
• Elevated Endothelial Hypoxia-Inducible Factor-1&agr; Contributes to Glomerular Injury and Promotes Hypertensive Chronic Kidney Disease

  2015cites this paper
• BQ-123 prevents LPS-induced preterm birth in mice via the induction of uterine and placental IL-10.

  2015cites this paper
• Linking the old and new — do angiotensin II type 1 receptor antibodies provide the missing link in the pathophysiology of preeclampsia?

  2015cites this paper
• Blocking Endogenous Leukemia Inhibitory Factor During Placental Development in Mice Leads to Abnormal Placentation and Pregnancy Loss

  2015cites this paper
• Four Pathways Involving Innate Immunity in the Pathogenesis of Preeclampsia

  2015cites this paper
• Proteinuria in Preeclampsia Excess LIGHT Contributes to Placental Impairment , Increased Secretion of Vasoactive

  2014cites this paper
• The relationship between Activin A and anti-angiogenic factors in the development of pre-eclampsia.

  2014cites this paper
• Antibodies in the Pathogenesis of Hypertension

  2014cites this paper
• Animal Models of Preeclampsia: Insight into Possible Biomarker Candidates for Predicting Preeclampsia

  2014cites this paper
• Excess LIGHT Contributes to Placental Impairment, Increased Secretion of Vasoactive Factors, Hypertension, and Proteinuria in Preeclampsia

  2014cites this paper
• Modelling aspects of preeclampsia in vitro and in vivo

  2014cites this paper
• Crosstalk between VEGF and BMP9 Signalling in the Context of Preeclampsia

  2013cites this paper
• Angiotensin Receptor Agonistic Autoantibody-Mediated Soluble Fms-Like Tyrosine Kinase-1 Induction Contributes to Impaired Adrenal Vasculature and Decreased Aldosterone Production in Preeclampsia

  2013cites this paper
• A leading role for the immune system in the pathophysiology of preeclampsia

  2013cites this paper
• Gestational Hypoxia Induces Preeclampsia-Like Symptoms via Heightened Endothelin-1 Signaling in Pregnant Rats

  2013cites this paper
• Gestational diabetes induces chronic hypoxia stress and excessive inflammatory response in murine placenta.

  2013cites this paper
• Angiotensin receptor agonistic autoantibodies and hypertension: preeclampsia and beyond.

  2013influential citation
• Elucidating immune mechanisms causing hypertension during pregnancy.

  2013cites this paper
• Hypoxia-Induced Pathways Associated With Hypertension During Pregnancy

  2013cites this paper
• Tumor Necrosis Factor‐Alpha, Interleukin‐6, and Interleukin‐10 Levels are Altered in Preeclampsia: A Systematic Review and Meta‐Analysis

  2013cites this paper
• Treg Cells Are Negatively Correlated with Increased Memory B Cells in Pre‐eclampsia While Maintaining Suppressive Function on Autologous B‐Cell Proliferation

  2013cites this paper
• Hypertension in the Pregnant Teenager

  2013cites this paper
• New therapeutic approaches to treating hypertension in pregnancy.

  2012cites this paper
• New frontiers in heart hypertrophy during pregnancy.

  2012cites this paper
• The Pathophysiology of Preeclampsia Involves Altered Levels of Angiogenic Factors Promoted by Hypoxia and Autoantibody-Mediated Mechanisms1

  2012cites this paper
• Effect of tocopherol supplementation during last trimester of pregnancy on mRNA abundances of interleukins and angiogenesis in ovine placenta and uterus

  2012cites this paper
• Autoantibody-Mediated Complement C3a Receptor Activation Contributes to the Pathogenesis of Preeclampsia

  2012cites this paper
• GPCRs as potential therapeutic targets in preeclampsia

  2012cites this paper
• Maternal Immune Dysregulation in the Pathogenesis of Neurodevelopmental Disorders: Interleukin-6 as a Central Mechanism and Therapeutic Target of Flavonoids

  2012cites this paper
• Review Article New frontiers in heart hypertrophy during pregnancy

  2012cites this paper
• GPCRs as potential therapeutic targets in preeclampsia.

  2012cites this paper
• Receptor-activating autoantibodies and disease: preeclampsia and beyond

  2011cites this paper
• Uterine Regulatory T cells, IL‐10 and Hypertension

  2011cites this paper
• Is inflammation the cause of pre-eclampsia?

  2011cites this paper
• Vascular Health and Risk Management Dovepress Preeclampsia: Long-term Consequences for Vascular Health

  year unknowncites this paper
• International Journal of Molecular Sciences the Endothelin Type a Receptor as a Potential Therapeutic Target in Preeclampsia

  year unknowncites this paper